Current Status and Future Perspective of Immunotherapy in Gastrointestinal Cancers
Gastrointestinal (GI) cancers represent a major public health problem worldwide. Due to the late detection and high heterogeneity of GI cancers, traditional treatments, including surgery, radiotherapy, chemotherapy, and targeted therapy, have shown limited effects, and the overall prognosis of these...
Main Authors: | Zhihao Lu, Zhi Peng, Chang Liu, Zhenghang Wang, Yakun Wang, Xi Jiao, Jian Li, Lin Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-08-01
|
Series: | The Innovation |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666675820300412 |
Similar Items
-
PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy
by: Junyu Long, et al.
Published: (2017-08-01) -
Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progress
by: Zin W. Myint, et al.
Published: (2017-04-01) -
Role of DNA repair defects in predicting immunotherapy response
by: Jing Zhang, et al.
Published: (2020-06-01) -
Review and perspective on adjuvant and neoadjuvant immunotherapies in NSCLC
by: Yi C, et al.
Published: (2019-09-01) -
Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges
by: Jing Jin, et al.
Published: (2020-05-01)